Zi-Yu Deng

722 total citations
15 papers, 596 citations indexed

About

Zi-Yu Deng is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Zi-Yu Deng has authored 15 papers receiving a total of 596 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Cancer Research and 3 papers in Epidemiology. Recurrent topics in Zi-Yu Deng's work include Cancer-related molecular mechanisms research (6 papers), RNA modifications and cancer (4 papers) and Circular RNAs in diseases (4 papers). Zi-Yu Deng is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), RNA modifications and cancer (4 papers) and Circular RNAs in diseases (4 papers). Zi-Yu Deng collaborates with scholars based in China and Uzbekistan. Zi-Yu Deng's co-authors include Hui Tao, Jingjing Yang, Kai‐Hu Shi, Wei Hu, Liping Liu, Peng Shi, ­Jun Li­, Chen Dai, Jun Li and Jun Li and has published in prestigious journals such as Molecular Cancer, International Journal of Biological Macromolecules and Metabolism.

In The Last Decade

Zi-Yu Deng

15 papers receiving 589 citations

Peers

Zi-Yu Deng
Karina Cunha e Rocha United States
Zi-Yu Deng
Citations per year, relative to Zi-Yu Deng Zi-Yu Deng (= 1×) peers Karina Cunha e Rocha

Countries citing papers authored by Zi-Yu Deng

Since Specialization
Citations

This map shows the geographic impact of Zi-Yu Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zi-Yu Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zi-Yu Deng more than expected).

Fields of papers citing papers by Zi-Yu Deng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zi-Yu Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zi-Yu Deng. The network helps show where Zi-Yu Deng may publish in the future.

Co-authorship network of co-authors of Zi-Yu Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Zi-Yu Deng. A scholar is included among the top collaborators of Zi-Yu Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zi-Yu Deng. Zi-Yu Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Chen, Shengkan, Zi-Yu Deng, Qinglan Tang, et al.. (2024). Integration analysis of transcriptome and proteome profiles brings new insights of somatic embryogenesis of two eucalyptus species. BMC Plant Biology. 24(1). 561–561. 2 indexed citations
2.
Tao, Hui, Zhengyu Song, Peng Shi, et al.. (2019). MeCP2 triggers diabetic cardiomyopathy and cardiac fibroblast proliferation by inhibiting RASSF1A. Cellular Signalling. 63. 109387–109387. 19 indexed citations
3.
Xu, Tao, Jie Min, Li Li, et al.. (2018). Pathological bases and clinical impact of long noncoding RNAs in prostate cancer: a new budding star. Molecular Cancer. 17(1). 103–103. 43 indexed citations
4.
Tao, Hui, Chen Dai, Peng Shi, et al.. (2017). LncRNA GAS5 controls cardiac fibroblast activation and fibrosis by targeting miR-21 via PTEN/MMP-2 signaling pathway. Toxicology. 386. 11–18. 119 indexed citations
5.
Tao, Hui, Jingjing Yang, Wei Hu, et al.. (2016). Noncoding RNA as regulators of cardiac fibrosis: current insight and the road ahead. Pflügers Archiv - European Journal of Physiology. 468(6). 1103–1111. 22 indexed citations
6.
Wang, Yuan Yuan, Chen Chen, Zi-Yu Deng, et al.. (2016). Repression of TSC1/TSC2 mediated by MeCP2 regulates human embryo lung fibroblast cell differentiation and proliferation. International Journal of Biological Macromolecules. 96. 578–588. 11 indexed citations
7.
Yang, Jingjing, Liping Liu, Hui Tao, et al.. (2016). MeCP2 silencing of LncRNA H19 controls hepatic stellate cell proliferation by targeting IGF1R. Toxicology. 359-360. 39–46. 48 indexed citations
8.
Yang, Jingjing, Hui Tao, Liping Liu, et al.. (2016). miR-200a controls hepatic stellate cell activation and fibrosis via SIRT1/Notch1 signal pathway. Inflammation Research. 66(4). 341–352. 40 indexed citations
9.
Tao, Hui, Jingjing Yang, Xiao Zhou, et al.. (2015). Emerging role of long noncoding RNAs in lung cancer: Current status and future prospects. Respiratory Medicine. 110. 12–19. 36 indexed citations
10.
Yang, Jingjing, Hui Tao, Zi-Yu Deng, Chao Lü, & ­Jun Li­. (2015). Non-coding RNA-mediated epigenetic regulation of liver fibrosis. Metabolism. 64(11). 1386–1394. 39 indexed citations
11.
Tao, Hui, Jingjing Yang, Wei Hu, et al.. (2015). MeCP2 regulation of cardiac fibroblast proliferation and fibrosis by down-regulation of DUSP5. International Journal of Biological Macromolecules. 82. 68–75. 21 indexed citations
12.
Yang, Jingjing, Hui Tao, Wei Hu, et al.. (2014). MicroRNA-200a controls Nrf2 activation by target Keap1 in hepatic stellate cell proliferation and fibrosis. Cellular Signalling. 26(11). 2381–2389. 81 indexed citations
13.
Li, Liucheng, Delin Li, Liang Xu, et al.. (2014). Total extract of Yupingfeng attenuates bleomycin-induced pulmonary fibrosis in rats. Phytomedicine. 22(1). 111–119. 48 indexed citations
14.
Tao, Hui, Jingjing Yang, Kai‐Hu Shi, Zi-Yu Deng, & ­Jun Li­. (2014). DNA methylation in cardiac fibrosis: New advances and perspectives. Toxicology. 323. 125–129. 33 indexed citations
15.
Deng, Zi-Yu, et al.. (2009). Effect of oxymatrine on the p38 mitogen-activated protein kinases signalling pathway in rats with CCl4 induced hepatic fibrosis.. PubMed. 122(12). 1449–54. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026